Literature DB >> 10074549

Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.

P E Verweij1, K Brinkman, H P Kremer, B J Kullberg, J F Meis.   

Abstract

The performance of antibody detection, antigen detection, and Aspergillus genus-specific PCR for diagnosing Aspergillus meningitis was investigated with 26 cerebrospinal fluid (CSF) samples obtained from a single patient with proven infection caused by Aspergillus fumigatus. Immunoglobulin G antibodies directed against Aspergillus were not detected by enzyme-linked immunosorbent assay in CSF or serum. The antigen galactomannan was detected in the CSF 45 days before a culture became positive, and Aspergillus DNA was detected 4 days prior to culture. Decline of the galactomannan antigen titer in the CSF during treatment with intravenous and intraventricular amphotericin B and intravenous voriconazole corresponded with the clinical response to treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074549      PMCID: PMC88672     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus.

Authors:  M Lammens; W Robberecht; M Waer; H Carton; R Dom
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

2.  Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

Authors:  S Schwartz; D Milatovic; E Thiel
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

3.  Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.

Authors:  J R Perfect; D T Durack
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

4.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease.

Authors:  S Kloss; A Schuster; H Schroten; J Lamprecht; V Wahn
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

6.  Hypertrophic cranial pachymeningitis due to Aspergillus flavus.

Authors:  H Murai; J Kira; T Kobayashi; I Goto; H Inoue; K Hasuo
Journal:  Clin Neurol Neurosurg       Date:  1992       Impact factor: 1.876

7.  Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.

Authors:  A Espinel-Ingroff; K Dawson; M Pfaller; E Anaissie; B Breslin; D Dixon; A Fothergill; V Paetznick; J Peter; M Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Western blot analysis of cerebrospinal fluid for detection of Aspergillus antigens.

Authors:  P Ray; A Chakrabarti; M Jatana; B S Sharma; A Pathak
Journal:  Mycopathologia       Date:  1995-08       Impact factor: 2.574

9.  Aspergillosis of the cerebral ventricles in a heroin abuser. Case report and review of the literature.

Authors:  R Morrow; B Wong; W E Finkelstein; S S Sternberg; D Armstrong
Journal:  Arch Intern Med       Date:  1983-01

10.  Amphotericin B-induced myelopathy.

Authors:  N T Carnevale; J N Galgiani; D A Stevens; M K Herrick; J W Langston
Journal:  Arch Intern Med       Date:  1980-09
View more
  31 in total

1.  Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay.

Authors:  M Hummel; B Spiess; K Kentouche; S Niggemann; C Böhm; S Reuter; M Kiehl; H Mörz; R Hehlmann; D Buchheidt
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients.

Authors:  D van de Beek; R Patel; N G Campeau; A Badley; J E Parisi; A A Rabinstein; E M Manno; E F M Wijdicks
Journal:  Neurology       Date:  2008-06-10       Impact factor: 9.910

4.  CNS Mold Infections.

Authors:  Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2013-10-13       Impact factor: 3.725

5.  Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Reflections on the approach to treatment of a mycologic disaster.

Authors:  David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

7.  Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples.

Authors:  B Posteraro; M Sanguinetti; L Masucci; L Romano; G Morace; G Fadda
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

8.  Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.

Authors:  Eric Nulens; Cathrien Eggink; Antonius J M M Rijs; Pieter Wesseling; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Cerebral aspergillosis in an infant with corticosteroid-resistant nephrotic syndrome.

Authors:  Emmanuel Roilides; Efterpi Pavlidou; Frantzis Papadopoulos; Christos Panteliadis; Evangelia Farmaki; Maria Tamiolaki; John Sotiriou
Journal:  Pediatr Nephrol       Date:  2003-03-18       Impact factor: 3.714

10.  Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.

Authors:  Jonathan R Genzen; Barton Kenney
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08-29       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.